SUNRISE HOSPITAL AND MEDICAL CENTER
Las Vegas, NV · CCN 290003 · Rates published
750,336 of 1,269,494 rate rows are consumer-grade (59.1%)
519,158 rows are marked excluded from the consumer medians — these stay visible in the raw drill-down with the same reason shown here, so nothing is silently hidden.
| Excluded — reason | Rows |
|---|---|
| professional (physician) fee — not the facility price | 495,816 |
| per-diem day rate — not a per-procedure price | 11,355 |
| no usable negotiated amount (only an out-of-band fallback) — excluded from medians | 9,286 |
| placeholder amount (≤ $0.02) — excluded from medians | 2,032 |
| template filing: same amount across many unrelated codes — excluded | 567 |
| exceeds 10× this hospital's gross charge — excluded from medians | 102 |
| Source MRF file | https://core.secure.ehc.com/src/util/detail-price-list/62-1762537_sunrise-hospital-and-medical-center_standardcharges.csv |
|---|---|
| Found on page | https://mountainview-hospital.com/about/legal/pricing-transparency-cms-required-file-of-standard-charges.dot |
| Discovered via | Discovered by HANK |
| Last fetch | Latest re-check couldn't be parsed — showing last good data · 2026-06-18 |
Top 50 most expensive offerings
Outliers are flagged where this hospital's filed rate is ≥2× or ≤0.5× the national median for the same code.
| Code | Description | Payers | Min $ | Max $ | Avg median | vs national |
|---|---|---|---|---|---|---|
|
00845 OTHER |
Inj, Atidarsagene Autotem | 1 | $4,505,000.00 | $4,505,000.00 | $4,505,000.00 |
nat. median $4,505,000 1.0× median |
|
845 OTHER |
Inj, Atidarsagene Autotem | 12 | $6,236.64 | $4,955,500.00 | $4,505,000.00 |
nat. median $9,966 outlier · 452.1× |
|
9138 OTHER |
Inj, Hemgenix, Per Tx Dos | 12 | $552,790.05 | $4,422,320.40 | $3,685,267.00 |
nat. median $3,746,358 1.0× median |
|
09138 OTHER |
Inj, Hemgenix, Per Tx Dos | 1 | $3,685,267.00 | $3,685,267.00 | $3,685,267.00 |
nat. median $3,574,709 1.0× median |
|
J1414 HCPCS |
Injection, Fidanacogene Elaparvovec-dzkt, Per Therapeutic Dose | 1 | $3,500,490.28 | $3,500,490.28 | $3,500,490.28 |
nat. median $3,710,000 0.9× median |
|
00908 OTHER |
Topi Adm Prad Zami Per Tr | 1 | $3,335,820.00 | $3,335,820.00 | $3,335,820.00 |
nat. median $12,675 outlier · 263.2× |
|
908 OTHER |
Topi Adm Prad Zami Per Tr | 13 | $11,292.32 | $4,002,984.00 | $3,335,820.00 |
nat. median $22,747 outlier · 146.6× |
|
714 OTHER |
Inj Delandistrogene Mox R | 13 | $7,335.12 | $3,993,432.00 | $3,327,860.00 |
nat. median $13,041 outlier · 255.2× |
|
00714 OTHER |
Inj Delandistrogene Mox R | 1 | $3,327,860.00 | $3,327,860.00 | $3,327,860.00 |
nat. median $3,228,024 1.0× median |
|
748 OTHER |
Inj, Lovotibeglogene Auto | 13 | $13,962.33 | $3,903,009.60 | $3,252,508.00 |
nat. median $17,963 outlier · 181.1× |
|
00748 OTHER |
Inj, Lovotibeglogene Auto | 1 | $3,252,508.00 | $3,252,508.00 | $3,252,508.00 |
nat. median $3,187,420 1.0× median |
|
J1411 HCPCS |
Injection, Etranacogene Dezaparvovec-drlb, Per Therapeutic Dose | 3 | $2,968,000.00 | $3,444,000.00 | $3,206,000.00 |
nat. median $3,710,000 0.9× median |
|
C9172 HCPCS |
Injection, Fidanacogene Elaparvovec-dzkt, Per Therapeutic Dose | 2 | $2,884,000.00 | $3,500,490.28 | $3,192,245.14 |
nat. median $3,570,000 0.9× median |
|
00906 OTHER |
Inj Elivaldogene Autoteme | 1 | $3,180,000.00 | $3,180,000.00 | $3,180,000.00 |
nat. median $21 outlier · 153697.4× |
|
906 OTHER |
Inj Elivaldogene Autoteme | 13 | $9,978.09 | $3,816,000.00 | $3,180,000.00 |
nat. median $20,756 outlier · 153.2× |
|
00746 OTHER |
Inj, Betibeglogene Autote | 1 | $2,939,969.00 | $2,939,969.00 | $2,939,969.00 |
nat. median $2,878,960 1.0× median |
|
746 OTHER |
Inj, Betibeglogene Autote | 13 | $12,915.31 | $3,527,962.80 | $2,939,969.00 |
nat. median $21,896 outlier · 134.3× |
|
J1413 HCPCS |
Injection, Delandistrogene Moxeparvovec-rokl, Per Therapeutic Dose | 2 | $2,636,800.00 | $3,200,490.28 | $2,918,645.14 |
nat. median $3,325,455 0.9× median |
|
J3394 HCPCS |
Injection, Lovotibeglogene Autotemcel, Per Treatment | 2 | $2,628,800.00 | $3,100,490.28 | $2,864,645.14 |
nat. median $3,286,000 0.9× median |
|
09141 OTHER |
Inj Onase Abepar-xioi Tre | 1 | $2,588,981.00 | $2,588,981.00 | $2,588,981.00 |
nat. median $2,457,321 1.1× median |
|
9141 OTHER |
Inj Onase Abepar-xioi Tre | 12 | $388,347.15 | $3,106,777.20 | $2,588,981.00 |
nat. median $2,588,981 1.0× median |
|
J3393 HCPCS |
Injection, Betibeglogene Autotemcel, Per Treatment | 2 | $2,374,400.00 | $2,800,490.28 | $2,587,445.14 |
nat. median $3,006,423 0.9× median |
|
00824 OTHER |
Inj, Exagamglogene Autote | 1 | $2,332,000.00 | $2,332,000.00 | $2,332,000.00 |
nat. median $2,332,000 1.0× median |
|
824 OTHER |
Inj, Exagamglogene Autote | 13 | $15,123.50 | $2,798,400.00 | $2,332,000.00 |
nat. median $25,250 outlier · 92.4× |
|
J3392 HCPCS |
Injection, Exagamglogene Autotemcel, Per Treatment | 1 | $2,200,490.28 | $2,200,490.28 | $2,200,490.28 |
nat. median $2,448,600 0.9× median |
|
J3399 HCPCS |
Injection, Onasemnogene Abeparvovec-xioi, Per Treatment, Up To 5x10°15 Vector Ge… | 3 | $1,842,227.74 | $2,322,534.64 | $2,082,381.19 |
nat. median $2,469,189 0.8× median |
|
Q2057 HCPCS |
Afamitresgene Autoleucel, Including Leukapheresis And Dose Preparation Procedure… | 4 | $732,102.01 | $1,656,833.00 | $1,656,833.00 |
nat. median $824,563 outlier · 2.0× |
|
2067 OTHER |
Afamitresgene Autoleucel | 12 | $115,593.00 | $924,744.00 | $770,620.00 |
nat. median $786,032 1.0× median |
|
415455 CDM |
Kit Hrt Implant Lvas | 10 | $243,777.39 | $1,166,399.00 | $717,335.39 |
nat. median $717,335 1.0× median |
|
Q2058 HCPCS |
Obecabtagene Autoleucel, 10 Up To 400 Million Cd19 Car-positive Viable T Cells,… | 2 | $598,237.50 | $598,237.50 | $598,237.50 |
nat. median $324,450 1.8× median |
|
09498 OTHER |
Ciltacabtagene Car-pos T | 1 | $587,649.60 | $587,649.60 | $587,649.60 |
nat. median $554,552 1.1× median |
|
9498 OTHER |
Ciltacabtagene Car-pos T | 12 | $88,147.44 | $705,179.52 | $587,649.60 |
nat. median $587,650 1.0× median |
|
9194 OTHER |
Tisagenlecleucel Car-pos | 12 | $84,979.70 | $679,837.56 | $566,531.30 |
nat. median $566,531 1.0× median |
|
09194 OTHER |
Tisagenlecleucel Car-pos | 1 | $566,531.30 | $566,531.30 | $566,531.30 |
nat. median $538,205 1.1× median |
|
9413 OTHER |
Lisocabtagene Car Pos T | 12 | $84,330.18 | $674,641.44 | $562,201.20 |
nat. median $562,201 1.0× median |
|
09413 OTHER |
Lisocabtagene Car Pos T | 1 | $562,201.20 | $562,201.20 | $562,201.20 |
nat. median $534,091 1.1× median |
|
09422 OTHER |
Idecabtagene Vicleucel Ca | 1 | $558,081.80 | $558,081.80 | $558,081.80 |
nat. median $530,178 1.1× median |
|
9422 OTHER |
Idecabtagene Vicleucel Ca | 12 | $83,712.27 | $669,698.16 | $558,081.80 |
nat. median $558,082 1.0× median |
|
Q2056 HCPCS |
Ciltacabtagene Autoleucel, Up To 100 Million Autologous B-cell Maturation Antige… | 8 | $405,756.74 | $1,263,446.58 | $553,169.00 |
nat. median $675,122 0.8× median |
|
Q2042 HCPCS |
Tisagenlecleucel, Up To 600 Million Car-positive Viable T Cells, Including Leuka… | 8 | $408,858.00 | $1,218,042.30 | $538,217.75 |
nat. median $754,974 0.7× median |
|
09035 OTHER |
Axicabtagene Ciloleucel C | 1 | $532,192.20 | $532,192.20 | $532,192.20 |
nat. median $505,583 1.1× median |
|
9035 OTHER |
Axicabtagene Ciloleucel C | 12 | $79,828.83 | $638,630.64 | $532,192.20 |
nat. median $532,192 1.0× median |
|
Q2055 HCPCS |
Idecabtagene Vicleucel, Up To 510 Million Autologous B-cell Maturation Antigen (… | 7 | $387,752.24 | $1,199,875.72 | $530,190.66 |
nat. median $625,184 0.8× median |
|
Q2054 HCPCS |
Lisocabtagene Maraleucel, Up To 110 Million Autologous Anti-cd19 Car-positive Vi… | 8 | $379,082.81 | $1,208,732.67 | $516,726.08 |
nat. median $674,188 0.8× median |
|
Q2041 HCPCS |
Axicabtagene Ciloleucel, Up To 200 Million Autologous Anti-cd19 Car Positive Via… | 8 | $359,552.00 | $1,144,213.32 | $502,841.00 |
nat. median $634,511 0.8× median |
|
8414 APR_DRG |
Extensive Third Degree Burns With Skin Graft | 1 | $501,787.64 | $501,787.64 | $501,787.64 |
nat. median $160,267 outlier · 3.1× |
|
9391 OTHER |
Brexucabtagene Car Pos T | 12 | $73,417.53 | $587,340.24 | $489,450.20 |
nat. median $489,450 1.0× median |
|
09391 OTHER |
Brexucabtagene Car Pos T | 1 | $489,450.20 | $489,450.20 | $489,450.20 |
nat. median $464,978 1.1× median |
|
Q2053 HCPCS |
Brexucabtagene Autoleucel, Up To 200 Million Autologous Anti-cd19 Car Positive V… | 8 | $359,552.00 | $1,052,317.93 | $464,990.71 |
nat. median $620,080 0.7× median |
|
J3402 HCPCS |
Injection, Remestemcel-l-rknd, Per Therapeutic Dose | 4 | $191,598.58 | $433,588.39 | $433,588.39 |
nat. median $209,753 outlier · 2.1× |
Other procedures at this hospital
Browse this hospital's 38,263 published procedures. Use the slice to choose what to show, then sort or filter any column.